Weight-loss drug wars escalate as Novo Nordisk targets Eli Lilly ads in lawsuit
Novo Nordisk A/S sued Eli Lilly & Co., accusing its rival of misleading advertising as competition in the…
Novo Nordisk Weaves a Safety Net: Hemophilia Drug Advances as GLP-1 Revenue Faces Halving in 2027
Novo Nordisk is trying to rebuild its story on two fronts at once. The Danish drugmaker’s stock has…
Novo Nordisk GBS and MAHE to advance pharmacometrics research and talent development in India
Novo Nordisk GBS and MAHE to advance pharmacometrics research and talent development in India July 08, 2026 |…
New Weight Loss Drugs Preserve Muscle and Cut Fat
Nearly every pharmaceutical company you can name is chasing this tantalizing idea: hang on to your muscles while…
Novo Nordisk’s Pipeline Paradox: A $55 Billion Bet on Automation and a Quiet Drug Revolution
The market has handed Novo Nordisk a brutal 40% haircut over the past year, and the bears have…
Novo Nordisk Walks a Tightrope: Oral Wegovy Approved as Pipeline Drug Shines, Yet Hack and Rival Pre
The Danish pharmaceutical giant closed the week at €38.03, a modest 2% gain that does little to mask…
Decision expected on proposed addiction recovery facility in New Berlin
Decision expected Tuesday on contentious addiction recovery facility in New Berlin The Milwaukee Rescue Mission’s expansion project is…
Novo Nordisk’s Sickle Cell Drug Delivers as Buyback Program Advances
Novo Nordisk’s oral sickle cell drug etavopivat met Phase 3 goals, cutting painful crises by 27%. The success…
Novo Nordisk Ups the Ante with Wegovy HD Rollout
In a significant development for the weight-loss drug market, Novo Nordisk has introduced a higher-dose version of…
Novo Nordisk Faces Pivotal Moment in Oral Weight-Loss Drug Race
Novo Nordisk releases Wegovy pill data ahead of Lilly’s launch as analysts cut targets citing competition and pipeline…
Novo Nordisk’s Pipeline Successor Outperforms Flagship Weight-Loss Drug
New clinical data shows UBT251 leads to 9.8% weight loss vs. semaglutide’s 4.8%, as Novo Nordisk expands its…
Novo Nordisk Slashes U.S. Drug Prices in Competitive Countermove
Novo, Nordisk
26.03.2026 – 03:56:40 | boerse-global.de
Novo Nordisk cuts U.S. prices for Ozempic…